BMY (bristol myers squibb) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BMY (bristol myers squibb)

BMY 46.01

-0.1%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: leslie jo who wrote (20)	1/25/1998 4:24:00 AM
From: William Nelson	Read Replies (2) of 194

slightly off-topic: Forbes mentioned this month a new company PGNX, whose main current revenue comes from BMY. PGNX has a product in phase III trials and sounds pretty promising, yet there is no discussion of it. I started a thread (name: progenics), and I am trying to provoke some discussion in it as I am unable to find any info on the web beyond Yahoo news items. But those news items sound very promising. Pipeline seems pretty full for a co. with market cap $117M. I think there is essentially no downside for this reason, and the upside is substantial.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next